Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stem cells to treat lung disease in preterm infants

06.02.2014
Advances in neonatal care for very preterm infants have greatly increased the chances of survival for these fragile infants.

However, preterm infants have an increased risk of developing bronchopulmonary dysplasia (BPD), a serious lung disease, which is a major cause of death and lifelong complications.

In a new study scheduled for publication in The Journal of Pediatrics, researchers evaluated the safety and feasibility of using stem cell therapies on very preterm infants to prevent or treat BPD.

Won Soon Park, MD, PhD, and colleagues from Samsung Medical Center and Biomedical Research Institute, Seoul, Republic of Korea, conducted a phase I, single-center trial of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells to nine very preterm infants (24-26 weeks gestational age) who were at high risk of developing BPD.

All patients who received the treatment tolerated the procedure well without any immediate serious adverse effects. Thirty-three percent of treated infants developed moderate BPD and none developed severe BPD, and 72 percent of a matched comparison group developed moderate or severe BPD.

Another serious side effect of very preterm birth, retinopathy of prematurity requiring surgery, tended to occur less often in treated infants. Overall, all nine treated infants survived to discharge, and only three developed moderate BPD.

This phase I study suggests that intratracheal administration of mesenchymal stem cells is safe and feasible. According to Dr. Park, "These findings strongly suggest that phase II clinical trials are warranted to test the efficacy of mesencymal stem cell transplantation, which could lead to new therapies to prevent or cure BPD." Dr. Park and colleagues are currently conducting a long-term safety and follow-up study of these nine preterm infants (ClinicalTrials.gov: NCT01632475).

Becky Lindeman | EurekAlert!
Further information:
http://www.us.elsevierhealth.com

More articles from Health and Medicine:

nachricht Quick blood test for malaria
01.08.2014 | Siemens AG

nachricht Invasive lionfish likely safe to eat after all
01.08.2014 | University of Hawaii ‑ SOEST

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

Counting down to FEBS-EMBO 2014 in Paris, France

29.07.2014 | Event News

9th European Wood-Based Panel Symposium 2014 – meeting point for the wood-based material branch

24.07.2014 | Event News

“Lens on Life” - Artists and Scientists Explore Cell Divison

08.07.2014 | Event News

 
Latest News

Igniting a supernova explosion

01.08.2014 | Physics and Astronomy

When Particles Fall Left and Right at the Same Time

01.08.2014 | Physics and Astronomy

Quick blood test for malaria

01.08.2014 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>